Stay updated on Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page
- Check5 days agoChange DetectedThe study record now indicates that recruitment is closed to accrual. Additionally, new help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), and the footer revision note updated to Revision: v3.6.0, with a minor formatting change to the Intervention/Treatment label.SummaryDifference0.4%

- Check12 days agoChange DetectedFooter revision label updated from v3.5.4 to v3.5.5. This signals a minor update to the page's revision history without altering the study details presented.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedA new revision label 'Revision: v3.5.4' was added and the previous 'Revision: v3.5.3' was removed. This denotes a newer revision of the study record and acts as metadata rather than content changes.SummaryDifference0.1%

- Check48 days agoChange DetectedThe study page now shows Revision: v3.5.3. This indicates an updated revision of the study documents.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.5.2 has been added to the page, and the previous Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.